Artificial Intelligence in Medicine

Artificial Intelligence in Medicine is a monthly Elsevier journal founded in 1989 that publishes research on the theory and practice of artificial intelligence in medicine and health care, with a 2025 Journal Impact Factor of 7.8《医学人工智能》是（Elsevier）于 1989 年创办的月刊，发表人工智能在医学与卫生保健中的理论与实践研究，2025 年影响因子为 7.8。

Scope

• AI-based clinical decision support and medical knowledge engineering are core areas基于人工智能的临床决策支持与医学知识工程是核心领域。
• Knowledge-based and agent-based systems for medicine and health care are covered面向医学与卫生保健的知识系统与主体系统均在覆盖之列。
• Computational intelligence in biology and clinical medicine, including machine learning, is central计算智能在生物学与临床医学中的应用，包括机器学习，是核心内容。
• Natural language processing and text mining for biomedical and clinical text are addressed面向生物医学与临床文本的自然语言处理与文本挖掘亦受关注。
• Data analysis, mining and intelligent use of heterogeneous data sources for decision support are published该刊发表面向决策支持的数据分析、挖掘与异构数据源智能利用研究。
• Intelligent devices, instruments, automated reasoning and meta-reasoning in medicine are included医学中的智能设备、仪器、自动推理与元推理也包含在内。
• Methodological, philosophical, ethical and social issues of AI in health care complete the scope人工智能在卫生保健中的方法学、哲学、伦理与社会议题构成其范围的另一部分。

History

• The journal was established in 1989 by Elsevier as a forum for artificial intelligence in medicine该刊于 1989 年由（Elsevier）创办，作为医学人工智能的交流平台。
• It appears monthly and publishes original articles, reviews, methodological papers and special issues该刊为月刊，发表原创论文、综述、方法学论文与专刊。
• Its Journal Impact Factor moved from 5.326 in 2021 and 7.011 in 2022 to 6.2 in 2024 and 7.8 in 2025其影响因子由 2021 年的 5.326 与 2022 年的 7.011，变为 2024 年的 6.2 与 2025 年的 7.8。
• The journal reports a median of 12 days from submission to first decision and 303 days from submission to acceptance该刊报告自投稿至首次决定的中间时间为 12 天，自投稿至录用的中间时间为 303 天。
• It offers an open access option with an article processing charge of USD 3,440, while subscription publication remains free to authors该刊提供开放获取选项，文章处理费为 3440 美元，订阅模式发表则不向作者收费。
• It is indexed in Science Citation Index Expanded, Scopus and Ei Compendex该刊被（Science Citation Index Expanded）、（Scopus）与（Ei Compendex）收录。

Editors

• The editor-in-chief is Carlo Combi of the University of Verona in Italy现任主编为意大利（University of Verona）的（Carlo Combi）。
• Special issues are proposed to guest editors by the editor-in-chief, and external proposals are no longer considered专刊由主编向客座编辑发出邀约，不再接受外部提案。
• The journal does not publish conference volumes or conference papers, but substantially revised conference work may be submitted该刊不出版会议论文集或会议论文，但经实质性改写与扩展的会议成果可以投稿。
• Dedicated categories exist for PhD projects and for in memoriam papers on leading scientists该刊设有博士项目专栏以及纪念已故重要学者的文章栏目。
• Manuscripts must combine potential high impact in a medical domain with strong methodological novelty稿件须同时具备在某一医学领域的潜在高影响与较强的方法学新颖性。
• Articles are peer reviewed, and the editorial board spans medical informatics, biomedical engineering and computer science文章须经同行评审，编委会覆盖医学信息学、生物医学工程与计算机科学。